Results 91 to 100 of about 8,460 (122)

Multicentre retrospective real-world evidence study evaluating the effectiveness and safety of mirikizumab in patients with moderately to severely active ulcerative colitis. [PDF]

Prz Gastroenterol
Lamparski Ł, Karłowicz K, Tulewicz-Marti E, Mahadea D, Łykowska-Szuber L, Sarbinowska J, Gonciarz M, Kabała B, Szkudłapski D, Zawada I, Tarnowska M, Sójka A, Neubauer K, Stojek M, Adrych K, Romańczyk T, Romańczyk M, Chaber-Ciopińska A, Zagórowicz E, Michalak A, Cichoż-Lach H, Domżał-Magrowska D, Boduła A, Małecka-Wojciesko E, Walecka-Kapica E, Gąsiorowska A, Pietraszek A, Pol K, Nemeczek S, Filip R, Gawron-Kiszka M, Musialik J, Klufczyńska A, Piotrowicz G, Pietrzak A, Zwolińska-Wcisło M, Daniluk J, Kopertowska-Majchrzak M, Koza J, Kłopocka M, Rydzewska G, Lewandowski K.   +41 more
europepmc   +1 more source

Advances in the Treatment of Ulcerative Colitis-From Conventional Therapies to Targeted Biologics and Small Molecules. [PDF]

Int J Mol Sci
Wilk A, Pawłowski M, Balcerczak E, Jeleń A, Mirowski M, Szmajda-Krygier D.   +5 more
europepmc   +1 more source

pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment. [PDF]

Pharmaceutics
Gvozdeva Y, Staynova R.
europepmc   +1 more source

IgA Nephropathy: Mechanisms, Risk Stratification, and Precision Therapy. [PDF]

Diagnostics (Basel)
Alobaidi S.
europepmc   +1 more source

Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey. [PDF]

J Clin Med
D'Amico F, Jairath V, Paridaens K, Peyrin-Biroulet L, Danese S.   +4 more
europepmc   +1 more source

The Use and Role of Mesalamine in the Treatment of Ulcerative Colitis: A Literature Review. [PDF]

Cureus
Chand S, Bendagiri Matam M, Bhatt NK, Neelakantan Ramaswamy S, Harikrishnan S, Agarwal Y, Mohammed L.   +6 more
europepmc   +1 more source

Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial. [PDF]

J Crohns Colitis
Danese S, Dignass A, Laharie D, Limdi JK, Kempinski R, Lewis JD, Younes Z, Cohen E, Alaka K, Eastman WJ, Tian T, Redondo I, Rubin DT, Dubinsky M.   +13 more
europepmc   +1 more source

Faecal Calprotectin: A Non-Invasive Marker for Diagnosing and Monitoring Acute Diverticulitis. [PDF]

Med Sci (Basel)
Mohammed A, Baig Y, Butler AE.
europepmc   +1 more source

Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries. [PDF]

Paediatr Drugs
Gupte D, Suthar NR, MacDonald JK, Le J, Colman RJ, Feagan BG, Cheng C, Hanzel J, Ma C, Jairath V, Crowley E.   +10 more
europepmc   +1 more source

Fecal butyric acid as a predictive biomarker of endoscopic remission in inflammatory bowel disease: a multicenter prospective study. [PDF]

Prz Gastroenterol
Karłowicz K, Lewandowski K, Domżał-Magrowska D, Talar-Wojnarowska R, Skonieczna-Żydecka K, Marlicz W, Małecka-Wojciesko E, Rydzewska G.   +7 more
europepmc   +1 more source